Collabrx - collabrx.com - CollabRx, Inc.
General Information:
Latest News:
CollabRx Partners with Medical News Site to Launch Molecular Oncology Mobile App 24 Aug 2013 | 01:21 am
By Uduak Grace Thomas Last week, CollabRx announced that it is collaborating with MedPage Today, the medical news arm of digital health and wellness firm Everyday Health, to develop a mobile applicat...
CollabRx Reports First Quarter Fiscal Year 2014 Financial Results 14 Aug 2013 | 01:06 am
San Francisco, Calif., August 13, 2013 – CollabRx, Inc. (the “Company”) (NASDAQ: CLRX) today announced financial results for the first quarter of fiscal year 2014, which ended June 30, 2013. First Qu...
CollabRx Announces Oncology-Specific Mobile App with Leading Site for Healthcare Professionals, MedPage Today 13 Aug 2013 | 06:13 pm
San Francisco, August 13, 2013 – CollabRx, Inc. (NASDAQ: CLRX), a healthcare information technology company focused on informing clinical decision making in molecular medicine, today announced a multi...
CollabRx Launches Variant Interpretation Service With Initial Focus on Oncology 12 Aug 2013 | 10:39 pm
By Uduak Grace Thomas CollabRx this week launched its Genetic Variant Annotation, or GVA, service, which will provide variant interpretation services to the molecular diagnostics segment of the clini...
CollabRx Launches Commercial Service for the Interpretation of Clinical Cancer Sequencing 8 Aug 2013 | 06:07 pm
San Francisco, Calif., August 8, 2013 – CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced the launch of the c...
CollabRx Featured in Forbes Article: “Can We Build A Kickstarter For Cancer?” 6 Aug 2013 | 04:14 am
SAN FRANCISCO, Calif., August 5, 2013 — CollabRx, Inc. (CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, was featured a Forbes article “Can We Build...
CollabRx to Present at the 2013 Southern California Investor Conference 30 Jul 2013 | 06:13 pm
Data Analytics Company Informing Clinical Decisions in Molecular Medicine Scheduled to Present on August 8, 2013 SAN FRANCISCO, July 30, 2013 — CollabRx, Inc. (CLRX), a data analytics company focused...
CollabRx Retains Hayden IR to Develop Strategic Investor Relations Program 26 Jul 2013 | 01:08 am
SAN FRANCISCO, July 25, 2013 – CollabRx, Inc. (CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announced it has engaged Hayden IR, a 15-year-old, ...
CollabRx to Collaborate with the University of Chicago Medical Center on Clinical Cancer Sequencing and Interpretation 18 Jun 2013 | 05:40 pm
San Francisco, CA, June 18, 2013 – CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced a collaboration with the...
CollabRx to Collaborate with the University of Chicago Medical Center on Clinical Cancer Sequencing and Interpretation 18 Jun 2013 | 05:40 pm
San Francisco, CA, June 18, 2013 – CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced a collaboration with the...
